• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Vitamin D and derivatives

Isotachysterol (CAS No. 469-06-7): A Comprehensive Overview of Its Applications and Recent Research Findings

Isotachysterol, with the chemical identifier CAS No. 469-06-7, is a compound that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry due to its unique structural properties and biological activities. This compound, belonging to the sterol family, has been extensively studied for its potential applications in medicine, particularly in the context of cholesterol metabolism and related therapeutic interventions.

The molecular structure of Isotachysterol distinguishes it from other sterols through its specific isomeric configuration. This configuration imparts distinct biochemical properties that make it a valuable candidate for research in lipid metabolism. Recent studies have highlighted its role in modulating cholesterol levels, making it a promising candidate for the development of novel therapeutic agents targeting hypercholesterolemia and related cardiovascular disorders.

In the realm of academic research, Isotachysterol has been investigated for its potential to interact with cellular receptors and enzymes involved in cholesterol homeostasis. Studies have demonstrated that this compound can influence the activity of HMG-CoA reductase, a key enzyme in the mevalonate pathway responsible for cholesterol synthesis. The ability to modulate this enzyme suggests that Isotachysterol could be a viable therapeutic option for managing elevated cholesterol levels.

Moreover, recent advancements in biochemical research have uncovered the potential of Isotachysterol in combating age-related macular degeneration (AMD). AMD is a leading cause of irreversible vision loss, primarily due to oxidative stress and inflammation in the retinal pigment epithelium (RPE). Preclinical studies have indicated that Isotachysterol possesses antioxidant properties that can protect against oxidative damage and reduce inflammation, thereby potentially slowing the progression of AMD.

The structural uniqueness of Isotachysterol, as evidenced by its chemical formula and isomeric configuration, has also led to investigations into its potential role in anti-inflammatory therapies. Chronic inflammation is a hallmark of various diseases, including rheumatoid arthritis and inflammatory bowel disease. Research has shown that sterols, including Isotachysterol, can modulate inflammatory pathways by interacting with nuclear factor kappa B (NF-κB) and other transcription factors involved in inflammation.

In addition to its therapeutic applications, Isotachysterol has been explored for its potential role in enhancing cellular health and longevity. Studies have suggested that this compound can improve mitochondrial function by protecting against oxidative stress and promoting ATP production. This property makes it an attractive candidate for research aimed at extending healthy lifespan and mitigating age-related decline.

The synthesis and characterization of Isotachysterol have also been subjects of interest in synthetic chemistry. Researchers have developed novel synthetic routes to produce this compound with high purity and yield, enabling more extensive research into its biological activities. These advancements have not only facilitated preclinical studies but also opened avenues for industrial-scale production if future clinical trials validate its efficacy.

The pharmacokinetic properties of Isotachysterol, including its absorption, distribution, metabolism, and excretion (ADME), have been carefully evaluated to understand its potential as a drug candidate. Initial studies have revealed that this compound exhibits good oral bioavailability and moderate tissue distribution, suggesting that it could be administered orally for therapeutic purposes. Further research is ongoing to optimize these pharmacokinetic profiles for improved therapeutic efficacy.

The safety profile of Isotachysterol has also been a focus of recent studies. Toxicological assessments have been conducted to evaluate potential side effects and determine safe dosage ranges. Preliminary results indicate that Isotachysterol is well-tolerated at moderate doses but may cause mild gastrointestinal discomfort at higher concentrations. These findings are crucial for guiding future clinical trials and ensuring patient safety if this compound progresses to human testing.

The interdisciplinary nature of research on Isotachysterol underscores its significance in both academic and industrial settings. Collaboration between chemists, biochemists, pharmacologists, and clinicians has been instrumental in uncovering its diverse applications. This collaborative approach not only accelerates the pace of discovery but also ensures that research findings are translated into tangible benefits for patients.

In conclusion, Isotachysterol (CAS No. 469-06-7) represents a promising compound with multifaceted applications in pharmaceuticals and biotechnology. Its unique structural properties, coupled with recent research findings on its biological activities, position it as a valuable candidate for further exploration in therapeutic interventions targeting hypercholesterolemia, AMD, inflammation, and age-related decline. As research continues to uncover new insights into its mechanisms of action and pharmacological properties, the potential for harnessing the benefits of this compound remains highly promising.

• 67-97-0(Vitamin D3)
• 118117-31-0(26-Noroleana-7,9(11)-diene-3,29-diol,13-methyl-, (3a,13a,14b,20a)-)
• 144-68-3(Zeaxanthin)
• 19356-17-3(Calcifediol)
• 17592-07-3(Tachysterol 3)
• 63283-36-3(Calcifediol monohydrate)
• 50-14-6(Vitamin D2)
• 1173-13-3(Previtamin D3)
• 22350-41-0(5,6-trans-Vitamin D3)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)